Melanoma Metastatic clinical trials

Explore recruiting melanoma metastatic clinical trials.

Recruiting melanoma metastatic studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Melanoma Metastatic trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

BEPCOME-MB: Phase 2, randomised trial testing the addition of upfront stereotactic radiosurgery to binimetinib, encorafenib plus pembrolizumab in comparison with binimetinib, encorafenib plus pembrolizumab alone in patients with BRAFV600 mutationpositive melanoma with brain metastasis

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Adjuvant immunotherapy with anti-PD-1 monoclonal antibody Pembrolizumab (MK-3475) versus placebo after complete resection of high-risk Stage III melanoma: A randomized, double- blind Phase 3 trial of the EORTC Melanoma Group

Portugal, Sweden, Poland, Finland, Netherlands, Spain +7 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Melanoma Metastatic trials by city

Melanoma Metastatic in Toronto Melanoma Metastatic in Vancouver Melanoma Metastatic in Montreal Melanoma Metastatic in Calgary Melanoma Metastatic in Edmonton Melanoma Metastatic in Ottawa Melanoma Metastatic in Winnipeg Melanoma Metastatic in Quebec City Melanoma Metastatic in Hamilton Melanoma Metastatic in Kitchener Melanoma Metastatic in London Melanoma Metastatic in Halifax Melanoma Metastatic in New York Melanoma Metastatic in Los Angeles Melanoma Metastatic in Chicago Melanoma Metastatic in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease